Tilray Brands, Inc. (TLRY) Stock Drops Despite Market Gains: Important Facts to Note
Werte in diesem Artikel
In the latest close session, Tilray Brands, Inc. (TLRY) was down 4.34% at $1.66. The stock fell short of the S&P 500, which registered a gain of 0.34% for the day. At the same time, the Dow added 0.09%, and the tech-heavy Nasdaq gained 0.42%. The company's shares have seen an increase of 38.4% over the last month, surpassing the Medical sector's gain of 1.97% and the S&P 500's gain of 3.54%.The upcoming earnings release of Tilray Brands, Inc. will be of great interest to investors. The company's earnings report is expected on October 9, 2025. The company's upcoming EPS is projected at -$0.03, signifying a 25.00% increase compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $206.83 million, indicating a 3.39% upward movement from the same quarter last year. TLRY's full-year Zacks Consensus Estimates are calling for earnings of -$0.11 per share and revenue of $877.28 million. These results would represent year-over-year changes of -1200% and +6.81%, respectively. Investors should also note any recent changes to analyst estimates for Tilray Brands, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Tilray Brands, Inc. presently features a Zacks Rank of #3 (Hold). The Medical - Products industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 81, finds itself in the top 33% echelons of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tilray Brands, Inc. (TLRY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Tilray (ex Aphria) und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf note
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf note
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Tilray (ex Aphria)
Analysen zu Tilray (ex Aphria)
Datum | Rating | Analyst | |
---|---|---|---|
14.08.2019 | Tilray Buy | The Benchmark Company | |
05.06.2019 | Tilray Perform | Oppenheimer & Co. Inc. | |
15.05.2019 | Tilray Market Perform | BMO Capital Markets | |
21.02.2019 | Aphria Buy | Seaport Global Securities | |
21.02.2019 | Tilray Neutral | Seaport Global Securities |
Datum | Rating | Analyst | |
---|---|---|---|
14.08.2019 | Tilray Buy | The Benchmark Company | |
15.05.2019 | Tilray Market Perform | BMO Capital Markets | |
21.02.2019 | Aphria Buy | Seaport Global Securities | |
16.10.2018 | Tilray Buy | The Benchmark Company |
Datum | Rating | Analyst | |
---|---|---|---|
05.06.2019 | Tilray Perform | Oppenheimer & Co. Inc. | |
21.02.2019 | Tilray Neutral | Seaport Global Securities |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Tilray (ex Aphria) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen